World's Best Scientists 2026 revealed!
Current Opinion in Biotechnology
H-index 53

Current Opinion in Biotechnology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Biology and Biochemistry 83 160 226 45
Engineering and Technology 583 18 25 15

Additional Metrics

Number of Best Scientists*: 387
Documents by Best Scientists*: 412
Top 100 Ranked Scientists*: 17
SCIMAGO H-index: 247
SCIMAGO SJR: 1.864
Impact Factor: 7

Overview

Top Research Topics at Current Opinion in Biotechnology?

The journal was organized to reinforce research efforts on Computational biology, Biotechnology, Biochemistry, Nanotechnology and Biochemical engineering. Topics in Computational biology were tackled in line with various other fields like Genetics, Genome, Gene and Bioinformatics. In particular, the Biochemistry works presented emphasize discussions on Enzyme.

The study on Biochemical engineering presented is investigated in conjunction with research in Metabolic engineering.

  • Computational biology (16.19%)
  • Biotechnology (14.74%)
  • Biochemistry (10.22%)

What are the most cited papers published in the journal?

  • Luminescent quantum dots for multiplexed biological detection and imaging. (1808 citations)
  • Antibiotics and antibiotic resistance in water environments (1330 citations)
  • Recombinant protein expression in Escherichia coli. (1308 citations)

Research areas of the most cited articles at Current Opinion in Biotechnology:

The journal publications mainly tackle studies in Biotechnology, Biochemistry, Computational biology, Nanotechnology and Biochemical engineering. The most cited articles tackle studies in Metabolic engineering and the interrelated subject of Synthetic biology to gain insights into Biotechnology. The published papers focus on Computational biology but the discussions also offer insight into other areas such as Genetics, Protein engineering and Bioinformatics.

What topics the last edition of the journal is best known for?

  • Gene
  • Enzyme
  • DNA

The previous edition focused in particular on these issues:

The journal primarily focuses on research topics in Biochemical engineering, Metabolic engineering, Microbiome, Ecology and Gut flora. While it focused on Biochemical engineering, it was also able to explore topics like Flux (metabolism), Biofuel, CRISPR and Robustness (evolution). While Metabolic engineering is the focus of Current Opinion in Biotechnology, it also provided insights into the studies of Cellular metabolism, Directed evolution, Applications of artificial intelligence, Lignin and Biomass.

In it, Continuous Plankton Recorder and Environmental resource management are investigated in conjunction with one another to address concerns in Microbiome research. The work on Ecology tackled in it brings together disciplines like Microbial diversity, Disease and Aquaculture. The journal explores research in Enzyme alongside concepts in Computational biology and other areas of study in Gene.

The most cited articles from the last journal are:

  • Challenges and opportunities in biological funneling of heterogeneous and toxic substrates beyond lignin (2 citations)
  • The plant microbiota: composition, functions, and engineering. (1 citations)
  • The human gut microbiota during the initial stages of life: insights from bifidobacteria. (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Current Opinion in Biotechnology (based on the number of publications) are:

  • Jens Nielsen (20 papers) absent at the last edition,
  • Jean-Louis Boulay (20 papers) absent at the last edition,
  • Mattheos A. G. Koffas (17 papers) absent at the last edition,
  • Munis Dundar (16 papers) absent at the last edition,
  • Michael J. Betenbaugh (16 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Opinion in Biotechnology (based on the number of publications) are:

  • ETH Zurich (76 papers) absent at the last edition,
  • Max Planck Society (64 papers) absent at the last edition,
  • University of California, San Diego (55 papers) absent at the last edition,
  • University of Wisconsin-Madison (53 papers) absent at the last edition,
  • University of Agricultural Sciences, Dharwad (53 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2022 edition, 2.44% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 7.50% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.50% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.00% of all publications and 75.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Biotechnology

While the numerous research topics explored in this article enlighten us on the fascinating field of biotechnology, it's equally important to note the various career opportunities this field encompasses. A career in biotechnology offers promising prospects for both researchers and practitioners alike.

Those with a background in biochemistry or computational biology may find ample opportunities in research or academia. Meanwhile, individuals particularly interested in practical applications and real-world impact might choose to explore fields like biochemical engineering or metabolic engineering.

A remarkable career path that intersects the boundaries of healthcare and biotechnology is that of a licensed pharmacist. Pharmacists possess an in-depth understanding of the biochemical mechanisms and effects of drugs, making them an integral part of the healthcare system. For those seeking to leverage their knowledge of biotechnology and make a substantial difference in healthcare, becoming a licensed pharmacist could be a worthwhile pursuit.

Every region has particular licensing requirements and various considerations to be made beforehand. For instance, if we consider the state of New Jersey, there are specific steps to be followed. Learn more about how to become a licensed pharmacist in New Jersey.

Whether you choose to pursue a career in research, academia, or healthcare, the field of biotechnology is ripe with opportunities for growth and innovation. Its interdisciplinary nature makes it a dynamic and ever-evolving career path. Finally, regardless of your professional trajectory, remember that continuous learning and passion for science are the driving forces behind a successful career in biotechnology.

Top Publications

  • Microbial electrosynthesis from CO2: forever a promise?

    Antonin Prévoteau;Jose M Carvajal-Arroyo;Ramon Ganigué;Korneel Rabaey

    (2020)
    284 Citations
  • Renewable methanol and formate as microbial feedstocks

    Charles A.R. Cotton;Nico J. Claassens;Sara Benito-Vaquerizo;Arren Bar-Even

    (2020)
    257 Citations
  • Biotechnological upcycling of plastic waste and other non-conventional feedstocks in a circular economy

    Lars Mathias Blank;Tanja Narancic;Jörg Mampel;Till Tiso

    (2020)
    177 Citations
  • Antimicrobials for food and feed; a bacteriocin perspective

    Paula M O’Connor;Taís M Kuniyoshi;Ricardo Ps Oliveira;Colin Hill

    (2020)
    174 Citations
  • Recent advances in modular co-culture engineering for synthesis of natural products.

    Rufeng Wang;Shujuan Zhao;Zhengtao Wang;Mattheos Ag Koffas

    (2020)
    173 Citations
  • Machine learning applications in systems metabolic engineering.

    Gi Bae Kim;Won Jun Kim;Hyun Uk Kim;Sang Yup Lee

    (2020)
    142 Citations
  • Microalgae based production of single-cell protein.

    (2022)
    137 Citations
  • Enhancing phage therapy through synthetic biology and genome engineering

    Bryan R Lenneman;Jonas Fernbach;Martin J Loessner;Timothy K Lu

    (2021)
    115 Citations
  • Carbonic anhydrase for CO2 capture, conversion and utilization.

    (2022)
    93 Citations

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of related fields and online degree programs that complement a strong foundation in science. For those interested in healthcare, pursuing an rn to bsn program offers a flexible pathway to advance nursing skills alongside chemical knowledge, enhancing patient care and medical understanding.

Accelerated paths such as accelerated pharmacy programs are ideal for Chemistry graduates seeking to fast-track their careers in pharmaceutical sciences. These programs focus on drug development and patient treatment, closely aligning with chemical expertise.

Another career avenue includes becoming a pharmaceutical rep salary professional. This role leverages chemistry knowledge to effectively communicate complex drug information to healthcare providers, making it a lucrative and dynamic choice.

Additionally, professionals interested in administrative aspects of healthcare might consider becoming a certified professional coder (cpc). This certification supports healthcare systems by ensuring accurate medical coding and billing, an essential part of the medical field that complements scientific expertise.

Best Scientists Contributing to This Journal

Recently Published Articles